Newly Diagnosed Diabetes in Patients with COVID-19: Different Types and Short-Term Outcomes

Faculty Medicine Year: 2031
Type of Publication: ZU Hosted Pages:
Authors:
Journal: Tropical Medicine and Infectious Disease MDPI Volume:
Keywords : Newly Diagnosed Diabetes , Patients with COVID-19: Different    
Abstract:
A great global concern is currently focused on the coronavirus disease 2019 (COVID-19)pandemic and its associated morbidities. Aim of the study: The goal of this study was to determine the frequency of newly diagnosed diabetes mellitus (DM) and its different types among COVID-19 patients, Patients and method: 570 patients with confirmed COVID-19 were studied. All participants were classified as non-diabetic or newly discovered diabetic. According to hemoglobin A1c (HbA1c) and fasting insulin, newly discovered diabetic patients were further clnewly diagnosed diabetic Results: patients. DM was diagnosed in 77 patients (13.5%); 12 (2.1%) with pre-existing DM, 7 (1.2%) with new-onset type 1 DM, and 58 (10.2%) with new-onset type 2 DM. Significantly higher rates of severe infection and mortality (p < 0.001 and p = 0.046) were evident among diabetic patientsassified into pre-existing DM, new-onset type 1 DM, and new-onset type 2 DM. Conclusion :COVID-19 was associated with a new-onset of DM in 11.4% of all participants and expression of pre-existing DM in 2.1% of all participants, both being associated with severe infection. COVID-19 patients with newly diagnosed diabetes had high risk of mortality
   
     
 
       

Author Related Publications

  • Khalid Ahmed Mohammed Al-Banna, "Urinary Neutrophil Gelatinase-Associated Lipocalin as an early marker for diagnosis of diabetic nephropathy in T2DM patients and its correlation to albumin creatinine ratio", Association of Cell Biology Romania, 2021 More
  • Khalid Ahmed Mohammed Al-Banna, "Proinsulin/insulin ratio as a predictor of insulin resistance and B-cell dysfunction in obese Egyptians ((insulin resistance&B-cell dysfunction in obese Egyptians", Clinical Research and Reviews, 2019 More
  • Khalid Ahmed Mohammed Al-Banna, "Serum Pentraxin 3 level as a recent biomarker of diabetic retinopathy in Egyptian patients with diabetes", Elsevier Ltd, 2019 More
  • Khalid Ahmed Mohammed Al-Banna, "Effect of Glucagon Like Peptide 1|(GLP1) Analogues on Obese Egyptians with &without Diabetes", Medical Journal of Cairo University, 2019 More
  • Khalid Ahmed Mohammed Al-Banna, "Urinary Adiponectin as a Diagnostic and Prognostic Marker in Diabetic Nephropathy", Al Azhar Assiut Medical Journal, 2015 More

Department Related Publications

  • Ahmed Adel Hassan Muhamad, "التعدد الشكلى لجينات الصنف الثانى من مولدات المضادات المحمولة على كرات الدم البيضاء البشرية فى حالات اصابات الكلى المزروعة بارتجاع الالتهاب الكبدى الناتج عن الاجسام المضادة "أ"", لايوجد, 1900 More
  • Ehab Barsom Fahim Meawad, "انزيمات الميتالوبر تينيز البين خلوى الثالث والتاسع وحمض الهالورونيك فى مصل الرثيان المفصلى وعلاقته بالنشاط المرضى", لايوجد, 1900 More
  • Gehan Abdelkader Ibrahim, "اندونيلين -1 في مرض متلازمة ومقاومة الأنسولين", لايوجد, 1900 More
  • Gehan Abdelkader Ibrahim, "فيتامين ب 12 حمض الفوليك والهوموسيستين كعوامل خطورة لمرض قصور الشريان التاجي في المرضى المصريين", لايوجد, 1900 More
  • Hamed Abdelaziz Deraz, "تواتر اجسام الخلل الذاتى فى مرضى التهاب الكبد المزمن وفى حالة الاصابة بالبهارسيا وعدمها", لايوجد, 1900 More
Tweet